EWP
TMO icon

Elevation Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Elevation Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$77.6K Buy
115
+49
+74% +$29.1K 0.02% 254
2026
Q2 		$33.1K Hold
66
– – 0.01% 422
2026
Q1 		$32.4K Sell
66
-12
-15% -$6.51K 0.01% 298
2025
Q4 		$45.2K Buy
78
+1
+1% +$566 0.02% 255
2025
Q3 		$37.3K Buy
77
+20
+35% +$9.31K 0.01% 272
2025
Q2 		$23.1K Hold
57
– – 0.01% 307
2025
Q1 		$28.4K Hold
57
– – 0.01% 285
2024
Q4 		$29.7K Buy
57
+7
+14% +$3.85K 0.01% 282
2024
Q3 		$30.9K Hold
50
– – 0.01% 269
2024
Q2 		$27.6K Sell
50
-14
-22% -$8.02K 0.01% 266
2024
Q1 		$37.2K Sell
64
-97
-60% -$54.4K 0.02% 243
2023
Q4 		$81.5K Hold
161
– – 0.05% 170
2023
Q3 		$81.5K Sell
161
-32
-17% -$17.1K 0.07% 111
2023
Q2 		$101K Hold
193
– – 0.08% 101
2023
Q1 		$111K Buy
+193
New +$109K 0.1% 92

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Elevation Wealth Partners's TMO Position: Q3 2026 in Review

Elevation Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 74% in Q3 2026, buying an estimated $29.1K and bringing the position to 115 shares worth $77.6K. The position accounts for 0.02% of the portfolio, ranked #254.

Elevation Wealth Partners first reported a position in TMO in Q1 2023 and has held it in 15 quarters since. The position peaked at $111K in Q1 2023. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Elevation Wealth Partners held 115 shares of Thermo Fisher Scientific worth $77.6K as of Q3 2026.
  • Elevation Wealth Partners bought 49 Thermo Fisher Scientific shares in Q3 2026, an estimated $29.1K.
  • Thermo Fisher Scientific made up 0.02% of Elevation Wealth Partners's portfolio in Q3 2026, its #254 holding.
  • Elevation Wealth Partners first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 15 quarters since.
  • Elevation Wealth Partners's Thermo Fisher Scientific position peaked at $111K in Q1 2023.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.